Renowned luminaries in Personalized Medicine
Groundbreaking companies with emerging technologies
More than 1000 peers from around the globe
50 sessions in 3 parallel tracks

CO-HOSTED WITH
STANFORD HEALTH CARE, UCSF, & ORACLE

Personalized Medicine in Organ Transplantation

Patients who have undergone organ transplants require frequent monitoring to evaluate the organ’s graft status and to modulate a complex regimen of immunosuppressive medications. The earliest detection of immune activation and graft injury followed by therapeutic intervention leads to better outcomes. Today, noninvasive, molecular diagnostics using predictive biomarkers can detect the earliest signs of rejection, even weeks to months before functional failure, and pinpoint actionable causes, enabling precision modulation of therapy and improved outcomes in organ transplantation. In this session you’ll hear from three leaders who are at the forefront of developing commercialized molecular diagnostics for heart and kidney transplantation.

SPEAKERS

John Sninsky, Ph.D., Chief Scientific Officer, CareDx Inc.

John Sninsky, Ph.D. joined CareDx Inc. as Chief Scientific Officer in January 2015. CareDx, Inc., based in Brisbane, California, is a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value, non-invasive diagnostic surveillance solutions for transplant recipients. Read Full Bio

Roy First, M.D., Chief Medical Officer, Transplant Genomics, Inc

Roy First, M.D. is Chief Medical Officer at Transplant Genomics, Inc. Previously he was VP and Global Therapeutic Leader (Transplantation) at Astellas Pharma, and Medical Director of Kidney Transplantation at the University of Cincinnati. He has published more than 390 articles on transplantation, as well as 39 book chapters and two books. Read Full Bio

Minnie Sarwal, M.D., Ph.D., Professor of Surgery and Director of the Translational Transplant Research Program, UCSF

Minnie Sarwal has over 30 years of clinical experience and 25 years of research experience in translational immunogenetics, genomics, proteomics and informatics. She holds a PhD in Molecular Genetics from Cambridge University, under the mentorship of Nobel Laureate Sydney Brenner. Read Full Bio

 
Web Analytics